POSTER SESSION 3

Tuesday June 14, 2016: 8:00-9:00
Exhibition Space (30 Euston Square)

PS3

PS3-1

RESOURCE ALLOCATION, VALUES AND EQUITY: MAINTAINING EQUITY IN THE FACE OF ANONYMITY
Mike Paulden, MA., MSc., University of Alberta, Edmonton, AB, Canada and Christopher McCabe, PhD, Department of Emergency Medicine, University of Alberta, Edmonton, AB, Canada
PS3-2

EVALUATING THE COST-EFFECTIVENESS OF MONITORING TESTS
Mike Paulden, MA., MSc.1, Reza Mahjoub, PhD2, Philip Akude, MSc1, Chase Hollman1 and Christopher McCabe, PhD3, (1)University of Alberta, Edmonton, AB, Canada, (2)Department of Emergency Medicine, University of Alberta, EDmonton, AB, Canada, (3)Department of Emergency Medicine, University of Alberta, Edmonton, AB, Canada
PS3-3

ASSESSING THE CONTRIBUTION OF PATIENTS' PROXIMITY TO DEATH IN ECONOMIC EVALUATIONS IN PATIENTS WITH HER2+ METASTATIC BREAST CANCER: AN EVENT BASED ANALYSIS
Noman Paracha, MSc, Per-Olof Thuresson, MSc and Joshua Ray, MSc, F. Hoffmann La-Roche Ltd., Basel, Switzerland
PS3-4

HEALTH LOST BY CHOOSING THE WRONG INTERVENTION – THE CASE OF ORAL ANTICOAGULANTS
Torbjørn Wisløff, Norwegian Institute of Public Health & University of Oslo, Oslo, Norway
PS3-5

POTENTIAL ECONOMIC VALUE OF BIOMARKERS IN PERSONALIZED MEDICINE: AN EXEMPLARY ASSESSMENT STUDY IN HEART FAILURE DISEASE MANAGEMENT
Qi Cao, PhD1, Erik Buskens, MD, PhD2, Hans L. Hillege, PhD, MD2, Maarten J Postma, Prof1 and Douwe Postmus, PhD2, (1)University of Groningen, Groningen, Netherlands, (2)University Medical Center Groningen, Groningen, Netherlands
PS3-6

MAKING RESEARCH OUTPUTS ACCESSIBLE TO PEOPLE WITH KIDNEY DISEASE: IMPLEMENTING THE DIALYSIS DECISION AID BOOKLET
Hilary Bekker, BSc, Msc, PhD1, Anna Winterbottom, Bsc, MSc, PhD1, Andrew Mooney, MBChB, PHD2 and Martin Wilkie, MBChB; PHD3, (1)University of Leeds, Leeds, United Kingdom, (2)St James Teaching Hospital, Leeds, United Kingdom, (3)Sheffield NHS Foundation Trust, Sheffield, United Kingdom
PS3-7

UNDERSTANDING DOCTORS' PERCEPTIONS OF GOOD CLINICAL DECISION MAKING: AN INTERVIEW STUDY
Leila Mehdizadeh, BSc, PhD1, Hilary Bekker, BSc, Msc, PhD2, Vikram Jha, FRCOG, PhD3 and Naomi Quinton, BSc, MSc, PhD2, (1)University College London, London, United Kingdom, (2)University of Leeds, Leeds, United Kingdom, (3)University of Liverpool, Liverpool, United Kingdom
PS3-8

COMMUNICATING RISKS AND BENEFITS OF PREVENTIVE TUBERCULOSIS TREATMENT: AUSTRALIAN PHYSICIANS' PERSPECTIVES
Claudia C. Dobler, MBBS, MD, PhD, Sinthia Bosnic-Anticevich, BPharm Hons, PhD, MPS and Carol Armour, BPharm Hons, PhD, MPS, Woolcock Institute of Medical Research, University of Sydney, Glebe (Sydney), Australia
PS3-9

RISK COMMUNICATION AND DECISIONS IN DEMENTIA: PROFESSIONAL PRACTICE PERSPECTIVES
Brian Taylor, PhD and Mabel Stevenson, MA, Ulster University, Northern Ireland, United Kingdom
PS3-10

THE FEASIBILITY OF AN INNOVATIVE INTRA-OPERATIVE DECISION MAKING TRAINING COURSE
Chi-Chuan Yeh, MD, MEd1, Tzu-Wei Tseng1, Roger Kneebone2, Nick Sevdalis, MSc PhD3, Tzong-Shinn Chu1, Chiung-Nien Chen1 and Hong-Shiee Lai1, (1)National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan, (2)Imperial College London, London, United Kingdom, (3)King’s College London, London, UK, London, United Kingdom
PS3-11

ESTIMATING THE BENEFIT OF A NATIONAL PROVISION OF COCHRANE REVIEWS
Perke Jacobs and Gerd Gigerenzer, PhD, Max Planck Institute for Human Development, Berlin, Germany
PS3-12

PHYSICIAN CHARACTERISTICS THAT PROMOTE OR IMPEDE CONTEXTUALIZED CARE PLANNING
Alan Schwartz, PhD1, Carol Kamin, EdD1, Amy Binns-Calvey1, Gunjan Sharma, PhD2, Kali Cyrus, MPH, MD3 and Saul Weiner, MD4, (1)University of Illinois at Chicago, Chicago, IL, (2)Jesse Brown Veterans Affairs Medical Center, Chicago, IL, (3)Yale School of Medicine, New Haven, CT, (4)Hines Veterans Affairs Hospital, Hines, IL
PS3-13

CLINICAL RELEVANCE OF THE NON-VISUALISED APPENDIX ON ULTRASONOGRAPHY OF THE ABDOMEN IN CHILDREN WITH ABDOMINAL PAIN
PhuaHwee Tang, MBBS, MMed, FRCR,1, Sanjena Kumar Amuddhu2, Sophie Ong2, Weixiang Lim2, Candy Choo1, Te Lu Yap1 and Shireen Nah1, (1)KK Women's and Children's Hospital, Singapore, Singapore, (2)NUS, Singapore, Singapore
PS3-14

SELF-CONTROL AND HEALTH BEHAVIOUR CHANGE: A NEW BEHAVIOURAL ECONOMICS MODEL INCORPORATING COGNITIVE EFFORT
Lukasz Tanajewski, Division of Social Research in Medicines and Health, School of Pharmacy, University of Nottingham, Nottingham, United Kingdom
PS3-15

THE ROLE OF TELEHOMECARE ON BLOOD PRESSURE CONTROL IN PATIENTS WITH HEART FAILURE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN ONTARIO, CANADA
Valeria E. Rac, MD, PhD1, Yeva Sahakyan, MD, MPH2, Lusine Abrahamyan, MD, MPH, PhD1, Nida Shahid, HBSc., MSc (c.)2, Aleksandra Stanimirovic, MSc, PhD (candidate)2, Petros Pechlivanoglou, MSc, PhD2, Welson Ryan2, Nicholas Mitsakakis, MSc PhD1 and Murray Krahn, MD, MSc, FRCPC1, (1)Toronto Health Economics and Technology Assessment (THETA) Collaborative, Toronto, ON, Canada, (2)Toronto Health Economics and Technology Assessment (THETA) Collaborative, University of Toronto, Toronto, ON, Canada
PS3-16

THE ASSOCIATION BETWEEN HAVING A LONG-TERM CONDITION AND UPTAKE OF POPULATION-BASED SCREENING FOR COLORECTAL CANCER
Benjamin Kearns, BSc, MSc, The University of Sheffield, Sheffield, United Kingdom
PS3-17

DECISION ANALYTIC GUIDANCE OF DIAGNOSTIC TEST EVALUATION OBVIATES THE REQUIREMENT FOR RANDOMIZED TRIALS
Alvin I Mushlin, MD, ScM, Weill Cornell Medicine, Department of Healthcare Policy & Research, NY, NY
PS3-18

IMPROVING CANCER SCREENING INFORMATION: INSIGHTS FROM INDIVIDUAL DIFFERENCES IN INFORMATION PROCESSING
Kathryn Robb1, Lauren Gatting1, Ellen Peters, PhD2, Lesley McGregor3, Christian von Wagner3 and Jane Wardle3, (1)University of Glasgow, Glasgow, United Kingdom, (2)Ohio State University, Columbus, OH, (3)University College London, London, United Kingdom
PS3-19

THE INFLUENCE OF INCREMENTAL COST-EFFECTIVENESS RATIO ON HEALTH TECHNOLOGY ASSESSMENT OF CANCER SCREENING IN HONG KONG
Carlos King Ho Wong, PhD1, Brian Hung Hin Lang, MD2, Vivian Yawei Guo, PhD1 and Cindy Lo Kuen Lam, MD1, (1)Department of Family Medicine and Primary Care, The University of Hong Kong, Hong Kong Island, Hong Kong, (2)Department of Surgery, The University of Hong Kong, Hong Kong Island, Hong Kong
PS3-20

APPLICABILITY AND PSYCHOMETRIC EVALUATION OF UTILITY AND CANCER-SPECIFIC HEALTH-RELATED QUALITY OF LIFE MEASURES IN PATIENTS WITH INCIDENTAL THYROID NODULES
Carlos King Ho Wong, PhD, Department of Family Medicine and Primary Care, The University of Hong Kong, Hong Kong Island, Hong Kong and Brian Hung Hin Lang, MD, Department of Surgery, The University of Hong Kong, Hong Kong Island, Hong Kong
PS3-21

AN EMPIRICAL COMPARISON OF THREE VERSIONS OF THE TIME TRADE-OFF
Miguel Ángel Artaso, MSc and Francisco Javier Díez, PhD, UNED, Madrid, Spain
PS3-22

MULTI-CRITERIA DECISION ANALYSIS OF PHARMACOLOGICAL MAINTENANCE TREATMENT OPTIONS IN BIPOLAR DISORDER: EVALUATION OF AN EXPEDITE APPROACH
Oystein Eiring, MD, Cand Mag, PhDc1, Kjetil Gundro Brurberg, Dr Philos1, Jan Odgaard Jensen, PhD1, Brynjar Landmark, MD, Dr. Med2, Kari Nytroen, PhD3 and Magne Nylenna, MD, Dr Med4, (1)Norwegian Institute of Public Health, Oslo, Norway, (2)Innlandet Hospital Trust, Brumunddal, Norway, (3)Innlandet Hospital Trust, Furnes, Norway, (4)The Knowledge Center in the Norwegian Institute of Public Health, Oslo, Norway
PS3-23

PRODUCING QUALITY-ADJUSTED OPINIONS FOR PREFERENCE-SENSITIVE MULTI-CRITERIAL DECISION SUPPORT
Jack Dowie, PhD, LSHTM, London, United Kingdom, Mette Kjer Kaltoft, PhD, Odense University Hospital - Svendborg, Svendborg, Denmark, Jesper Bo Nielsen, PhD, University of Southern Denmark, Odense, Denmark and Glenn Salkeld, PhD, University of Wollongong, Wollongong, Australia
See more of: 16th Biennial European Conference
<< Previous Session | Next Session >>